|Articles|April 20, 2023
Mass Spectra of Designer Drugs 2023
With a continued need for comprehensive forensic data to keep up with the rapid pace of designer drug synthesis, John Wiley & Sons have made a new mass spectral database designed for laboratory use. According to the company, this release features over 34,000 mass spectra of more than 26,000 unique chemical compounds with detailed information and chemical structures for each entry.
John Wiley & Sons, Inc.
Hoboken, New Jersey, USA
Related Content
Trending on LCGC International
1
Analytical Procedure Lifecycle Approaches in Accordance With ICH Q14 and ICH Q2(R2): Opportunity Knocks or Just Another Challenge and Headache? (Part 2)
2
HILIC vs Reversed-Phase LC for Central Carbon Metabolism Profiling
3
UHPLC–QTOF-MS Links Urine Profiles to ADHD
4
Beyond the Peak: What Keeps Women in Chromatography
5